AJP - Heart Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 278: H117-H125, 2000;
0363-6135/00 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Church, D. J.
Right arrow Articles by Lang, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Church, D. J.
Right arrow Articles by Lang, U.
Vol. 278, Issue 1, H117-H125, January 2000

Role of cell contractions in cAMP-induced cardiomyocyte atrial natriuretic peptide release

D. J. Church1, M. C. Rebsamen2, D. Morabito2, V. van der Bent2, M. B. Vallotton2, and U. Lang2

1 Serono, Geneva Pharmaceutical Research Institute, and 2 Division of Endocrinology, University Hospital, CH-1211 Geneva 14, Switzerland

Incubation of spontaneously beating ventricular cardiomyocytes from neonatal rats with prostaglandin E2 (0.1 µM) or forskolin (0.1 µM) simultaneously increased the rate of cellular contraction and atrial natriuretic peptide (ANP) secretion. Both responses were maximal within 10-20 min of application and were accompanied by three- to fourfold increases in cAMP formation. By contrast, a higher regimen of forskolin (10 µM) promoted a 20- to 30-fold increase in basal cAMP production, which was accompanied by the abolition of contractile activity and ANP release. Low regimens of forskolin (0.1 µM) doubled the occurrence of cytosolic Ca2+ transients associated with monolayer contraction, whereas higher regimens of forskolin (10 µM) completely suppressed Ca2+ transients. Moreover, in quiescent cultures that were pretreated with ryanodine, tetrodotoxin, nifedipine, or butanedione monoxime, prostaglandin E2 (0.1 µM) and forskolin (0.1 µM) failed to elicit significant ANP secretion, suggesting that cAMP-elevating agents promote ANP secretion to a great extent via an increase in cellular contraction frequency in ventricular cardiomyocytes.

ventricular cardiomyocytes; cell contractions; prostaglandin E2; forskolin; cytosolic calcium concentration


This article has been cited by other articles:


Home page
 Cardiovasc ResHome page
J. R. Dietz
Mechanisms of atrial natriuretic peptide secretion from the atrium
Cardiovasc Res, October 1, 2005; 68(1): 8 - 17.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. Y. Jin, J. F. Wen, D. Li, and K. W. Cho
Osmoregulation of atrial myocytic ANP release: osmotransduction via cross-talk between L-type Ca2+ channel and SR Ca2+ release
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2004; 287(5): R1101 - R1109.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
A. Arutunyan, L. M. Swift, and N. Sarvazyan
Initiation and propagation of ectopic waves: insights from an in vitro model of ischemia-reperfusion injury
Am J Physiol Heart Circ Physiol, August 1, 2002; 283(2): H741 - H749.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
D. J Autelitano, R. Ridings, and F. Tang
Adrenomedullin is a regulated modulator of neonatal cardiomyocyte hypertrophy in vitro
Cardiovasc Res, August 1, 2001; 51(2): 255 - 264.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online